For starters, it’s due to management distaste for the things. Given how funding for us research has been handled this year, that is sufficient to end considera

For starters, it’s due to management distaste for the things. Given how funding for us research has been handled this year, that is sufficient to end consideration for that approach. If not for vaccines in general.